Maria Teresa Mucignat
Overview
Explore the profile of Maria Teresa Mucignat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gambelli A, Nespolo A, Rampioni Vinciguerra G, Pivetta E, Pellarin I, Nicoloso M, et al.
EMBO Mol Med
. 2024 Jul;
16(8):1981.
PMID: 38997596
No abstract available.
2.
Gambelli A, Nespolo A, Rampioni Vinciguerra G, Pivetta E, Pellarin I, Nicoloso M, et al.
EMBO Mol Med
. 2024 Apr;
16(5):1162-1192.
PMID: 38658801
Platinum (PT)-resistant Epithelial Ovarian Cancer (EOC) grows as a metastatic disease, disseminating in the abdomen and pelvis. Very few options are available for PT-resistant EOC patients, and little is known...
3.
Capuano A, Fogolari F, Bucciotti F, Spessotto P, Nicolosi P, Mucignat M, et al.
Matrix Biol
. 2017 Oct;
66:50-66.
PMID: 29037761
EMILIN1, a homo-trimeric adhesive ECM glycoprotein, interacts with the α4β1 integrin through its gC1q domain. Uniquely among the C1q family members, the EMILIN1 gC1q presents only nine-stranded β-sandwich fold and...
4.
Cesaratto L, Grisard E, Coan M, Zandona L, De Mattia E, Poletto E, et al.
Cell Death Dis
. 2016 Dec;
7(12):e2526.
PMID: 28005076
No abstract available.
5.
Cesaratto L, Grisard E, Coan M, Zandona L, De Mattia E, Poletto E, et al.
Cell Death Dis
. 2016 Dec;
7(9):e2374.
PMID: 27899818
Rs3814113 is the single-nucleotide polymorphism (SNP) showing the strongest association with high-grade serous ovarian carcinoma (HGSOC) incidence and is located in an intergenic region about 44 kb downstream of basonuclin...
6.
Farnedi A, Rossi S, Bertani N, Gulli M, Silini E, Mucignat M, et al.
BMC Cancer
. 2015 May;
15:352.
PMID: 25935541
Background: Tumour relapse is recognized to be the prime fatal burden in patients affected by head and neck squamous cell carcinoma (HNSCC), but no discrete molecular trait has yet been...
7.
Girolamo F, Dallatomasina A, Rizzi M, Errede M, Walchli T, Mucignat M, et al.
PLoS One
. 2014 Jan;
8(12):e84883.
PMID: 24386429
NG2/CSPG4 is a complex surface-associated proteoglycan (PG) recognized to be a widely expressed membrane component of glioblastoma (WHO grade IV) cells and angiogenic pericytes. To determine the precise expression pattern...
8.
Magro G, Cataldo I, Amico P, Torrisi A, Vecchio G, Parenti R, et al.
Thyroid
. 2011 Feb;
21(3):267-77.
PMID: 21323588
Background: Type I receptor for transferrin (TfR1/CD71) is overexpressed in several malignant tumors, but no studies are available on thyroid carcinomas. Our previous comparative analyses of the relative distribution of...
9.
Spessotto P, Cervi M, Mucignat M, Mungiguerra G, Sartoretto I, Doliana R, et al.
J Biol Chem
. 2002 Nov;
278(8):6160-7.
PMID: 12456677
EMILIN-1 (Elastin Microfibril Interface Located ProteIN), the prototype of the EMILIN family, consists of a cysteine-rich domain (EMI domain) at the N terminus, an extended region with a high potential...
10.
Cattaruzza S, Schiappacassi M, Spessotto P, Perissinotto D, Morgelin M, Mucignat M, et al.
J Biol Chem
. 2002 Sep;
277(49):47626-35.
PMID: 12221092
We have carried out a comprehensive molecular mapping of PG-M/versican isoforms V0-V3 in adult human tissues and have specifically investigated how the expression of these isoforms is regulated in endothelial...